Dimensional Fund Advisors
IMNM icon

Dimensional Fund Advisors’s Immunome IMNM Stock Holding History

Dimensional Fund Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.43M Buy
438,241
+70,274
+19% +$1.74M ﹤0.01% 2290
2026
Q2 		$7.8M Buy
367,967
+334,559
+1,001% +$7.16M ﹤0.01% 2408
2026
Q1 		$731K Sell
33,408
-282,975
-89% -$6.3M ﹤0.01% 2892
2025
Q4 		$6.8M Sell
316,383
-21,972
-6% -$386K ﹤0.01% 2427
2025
Q3 		$3.96M Buy
338,355
+233,571
+223% +$2.32M ﹤0.01% 2606
2025
Q2 		$974K Buy
+104,784
New +$859K ﹤0.01% 2892
2024
Q1 		– Sell
-14,054
Closed -$150K – 3417
2023
Q4 		$150K Sell
14,054
-1,379
-9% -$11.5K ﹤0.01% 3234
2023
Q3 		$129K Hold
15,433
– – ﹤0.01% 3285
2023
Q2 		$122K Hold
15,433
– – ﹤0.01% 3301
2023
Q1 		$77K Buy
+15,433
New +$75.5K ﹤0.01% 3341

Other funds holding IMNM

Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Mitsubishi UFJ Asset Management (UK)
Mitsubishi UFJ Asset Management (UK) London, United Kingdom $213M AUM 36.38% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Magnus Financial Group
Magnus Financial Group New York $1.5B AUM 16.47% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Dimensional Fund Advisors's IMNM Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Immunome (IMNM) stake by 19% in Q3 2026, buying an estimated $1.74M and bringing the position to 438,241 shares worth $9.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2290.

Dimensional Fund Advisors first reported a position in IMNM in Q1 2023 and has held it in 10 quarters since. 48 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • Dimensional Fund Advisors held 438,241 shares of Immunome worth $9.43M as of Q3 2026.
  • Dimensional Fund Advisors bought 70,274 Immunome shares in Q3 2026, an estimated $1.74M.
  • Immunome made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2290 holding.
  • Dimensional Fund Advisors first reported a position in Immunome in Q1 2023 and has held it in 10 quarters since.
  • 48 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.